By Tom Hals and Stephen Nellis WILMINGTON, Delaware, Oct 9 (Reuters) – A lawsuit by chipmaker Qualcomm against chip technology supplier Arm Holdings will head on Friday to a jury charged with determining if Arm breached licensing agreements and intentionally sabotaged some of Qualcomm’s dealings with…
TURIN, Oct 9 (Reuters) – Stellantis CEO Antonio Filosa said on Friday the automaker’s partnership with British startup Wayve could help slash development times and costs for advanced driver-assistance systems as carmakers race to bring autonomous features to market. Speaking alongside Wayve CEO Alex Kendall…
By Timour Azhari and Tala Ramadan RIYADH/DUBAI, Oct 9 (Reuters) – Thursday’s attacks on Riyadh airport killed three people, Saudi authorities said on Friday, as Yemen’s Houthi group stepped up missile strikes on the kingdom and tried to shut down its airspace in an escalating…
By Tharuniyaa Lakshmi and Shashwat Chauhan Oct 9 (Reuters) – US stock index futures rose on Friday as oil prices retreated on easing Middle East supply concerns, though telecom shares remained under pressure after SpaceX’s spectrum acquisition raised competitive concerns across the sector. Oil prices…
GENEVA, Oct 9 (Reuters) – The United Nations human rights office on Friday welcomed the news of Navi Pillay’s Nobel Peace Prize win, acknowledging her longstanding advocacy for human rights. “It is amazing news, we need more dedication and commitment to human rights,” Shabia Mantoo,…
By Nancy Lapid Oct 9 (Reuters) – It’s Nobel Prize season and today we feature promising early results of a novel technique for treating blindness that made Nobel laureates of three scientists this week. We also report on two studies comparing treatment options presented at…
Oct 9 (Reuters) – Teva said on Friday it had received approval from the US Food and Drug Administration for Weltruza, a once-monthly injection for adults with schizophrenia. Weltruza is the second US-approved product from Israel-based Teva’s partnership with French biotech company Medincell after Uzedy, a…
Oct 9 (Reuters) – City Therapeutics on Friday said it is targeting a valuation of up to $956.3 million in its US initial public offering, as biotech companies press ahead with listings despite market uncertainty. • The Massachusetts-based company is seeking to raise up to…
Oct 9 (Reuters) – Humana’s shares rose 15% in premarket trading on Friday after analysts said the health insurer is the biggest beneficiary of the new star ratings for 2027 Medicare Advantage plans. Humana said 95% of its Medicare Advantage members will be enrolled in…
By Makini Brice and Dominique Vidalon PARIS, Oct 9 (Reuters) – French student unions vowed on Friday to keep up protests after scoring what they called their first win in a campaign that is increasingly supported by Paris’ elite universities, with 141 schools still shut…
